missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human ARD1A (aa 175-235) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (90%), Rat (90%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-56546 (PA5-56546. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
N-alpha-acetylation is one of the most common protein modifications that occurs during protein synthesis and involves the transfer of an acetyl group from acetyl-coenzyme A to the protein alpha-amino group. ARD1A, together with NATH.
Specifications
Specifications
| Accession Number | P41227 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 8260 |
| Name | Human ARD1A (aa 175-235) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 2310039H09Rik; alpha-N-acetyltransferase 1 A; ARD1; ARD1 homolog A, N-acetyltransferase; Ard1a; ARD1P; DXS707; hARD1; MCOPS1; N(alpha)-acetyltransferase 10, NatA catalytic subunit; N(alpha)-acetyltransferase 10, NatA catalytic subunitNalpha acetyltransferase 10; Naa10; N-acetyltransferase ARD1 homolog; N-acetyltransferase ARD1, human homolog of; Nalpha acetyltransferase 10; N-alpha-acetyltransferase 10; N-alpha-acetyltransferase 10, NatA catalytic subunit; natA catalytic subunit Naa10; NATD; N-terminal acetyltransferase complex ARD1 subunit homolog A; OGDNS; RGD1565315; Te2 |
| Common Name | ARD1A |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction